Study highlights missed revenue opportunities
Many community pharmacies are missing out on revenue opportunities from cardio vascular risk screening because they don’t know how to charge for it, according to a new survey.
This also means they are offering a sub-optimum service to patients, according to a report on the survey published in the journal Heart Lung and Circulation.
While most pharmacies offer blood pressure monitoring, a minority screen for multiple CVD risk factors, including total and HDL cholesterol, the survey of 294 Australian pharmacies found.
Lack of remuneration is the main barrier to offering expanded services, as many pharmacists have the capacity to screen for multiple risk factors.
Most survey respondents offer free heart health assessments but had calculated they needed to be paid between $10 and $50 for five to 30 minutes of consulting time.
However, patients are willing to pay, says pharmacist